The Bob Harrington Show

Bob Harrington, Erin Michos, and Brahmajee Nallamothu discuss how the publish or perish culture can lead to sloppy research and the need for alternative models to measure success in academic medicine.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington

With Great Power Comes Great Responsibility

Big Data Research From the National Inpatient Sample https://doi.org/10.1161/CIRCOUTCOMES.117.003846

Adherence to Methodological Standards in Research Using the National Inpatient Sample

https://doi.org/10.1001/jama.2017.17653

Publish or Perish: Where are we heading?

https://pubmed.ncbi.nlm.nih.gov/24778659

The Kardashian Index of Cardiologists: Celebrities or Experts? https://doi.org/10.1016/j.jaccas.2019.11.068

You may also like:

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback, please contact [email protected]

Bob Harrington and Mike Gibson discuss two of the hottest topics in cardiology and medicine for 2023: a proposed alternative to the maintenance of certification process, and artificial intelligence.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit

https://www.medscape.com/author/bob-harrington

Cardiovascular Organizations Pursue New, Independent Medical Board

https://www.acc.org/About-ACC/Press-Releases/2023/09/21/15/02/Cardiovascular-Organizations-Pursue-New-Independent-Medical-Board

The National Board of Physicians and Surgeons

https://nbpas.org/

Level of Scientific Evidence Underlying the Current American College of Cardiology/American Heart Association Clinical Practice Guidelines

https://doi.org/10.1161/CIRCOUTCOMES.118.005293

Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients https://www.abstractsonline.com/pp8/?_ga=2.17782015.7532578.1693882428-1949139275.1663003561#!/10871/presentation/16568

A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models

https://doi.org/10.1016/j.jclinepi.2019.02.004

Recognizing a ruler instead of a cancer

https://menloml.com/2020/01/11/recognizing-a-ruler-instead-of-a-cancer/

The Geographic Bias in Medical AI Tools

https://hai.stanford.edu/news/geographic-bias-medical-ai-tools

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback, please contact

[email protected]

For this year's review, Bob Harrington and Mike Gibson revisit the major cardiology conferences -- from ACC in New Orleans to AHA in Philly.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit:

https://www.medscape.com/author/bob-harrington

ACC 2023 Top Trials

- Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients: CLEAR Outcomes https://www.medscape.com/viewarticle/989100

- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

- Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616 https://www.jacc.org/doi/10.1016/j.jacc.2023.02.018

ACC/WCC 2023 Collection Page https://www.medscape.com/viewcollection/36966

ESC 2023 Top Trials

- Wegovy Scores HFpEF Benefits in People With Obesity https://www.medscape.com/viewarticle/995844

- Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity https://www.nejm.org/doi/full/10.1056/NEJMoa2306963

- Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy https://www.medscape.com/viewarticle/995883

ESC 2023 Collection Page https://www.medscape.com/viewcollection/36988

AHA 2023 Top Trials

- Semaglutide 'A New Pathway' to CVD Risk Reduction: SELECT https://www.medscape.com/viewarticle/998373

- Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

- Bariatric Surgery is Associated With Improved Coronary Microvascular Function and Cardiorespiratory Fitness in Patients With Ischemia and Non-Obstructive Coronary Arteries https://www.ahajournals.org/doi/10.1161/circ.148.suppl_1.18949

- Angioplasty Finally Proven Beneficial in Stable Angina: ORBITA-2 https://www.medscape.com/s/viewarticle/998375

- A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina https://www.nejm.org/doi/full/10.1056/NEJMoa2310610

- Impressive Bleeding Profile With Factor XI Inhibitor in AF: AZALEA https://www.medscape.com/viewarticle/998418

- Promising First Results With DNA Editing to Lower LDL https://www.medscape.com/s/viewarticle/998719

- Single Injection Reduces Blood Pressure for 6 Months: KARDIA-1 https://www.medscape.com/viewarticle/998666

AHA 2023 Collection Page https://www.medscape.com/viewcollection/37277

Other Mentions

- N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects https://www.nejm.org/doi/full/10.1056/NEJMc2031173

- Rimonabant: From RIO to Ban https://doi.org/10.1155%2F2011%2F432607

- Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial https://doi.org/10.1016/S0140-6736(17)32714-9

- Asundexian Phase 3 AF Study Halted for Lack of Efficacy https://www.medscape.com/viewarticle/998665

- Challenges in the Design and Interpretation of Noninferiority Trials https://www.nejm.org/doi/full/10.1056/nejmra1510063

- Milvexian for the Prevention of Venous Thromboembolism https://www.nejm.org/doi/full/10.1056/NEJMoa2113194

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback, please contact [email protected]

Bob Harrington and Manesh Patel discuss sudden cardiac death in athletes and the importance of the chain of survival.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit https://www.medscape.com/author/bob-harrington

COVID and the Athlete's Heart

https://www.medscape.com/viewarticle/945282

Outcomes Registry for Cardiac Conditions in Athletes

https://doi.org/10.1161/JAHA.122.029052

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

https://doi.org/10.1161/CIR.0000000000000937

Point-of-care screening for HFrEF using artificial intelligence during ECG-enabled stethoscope examination

https://doi.org/10.1016/s2589-7500(21)00256-9

International recommendations for electrocardiographic interpretation in athletes

https://doi.org/10.1093/eurheartj/ehw631

Elevation of Cardiac Troponins After Endurance Running Competitions

https://doi.org/10.1161/CIRCULATIONAHA.118.034655

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

https://doi.org/10.1001/jamacardio.2023.1042

Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations

https://doi.org/10.1161/CIR.0000000000000236

RACE-CARS Trial

https://racecarstrial.org/

AHA CPR Resources

https://cpr.heart.org/en/cpr-courses-and-kits/hands-only-cpr

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology https://www.medscape.com/twic

Questions or feedback, please contact [email protected]

Bob Harrington interviews Jag Singh about the COVID journey that led to his book, Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine.

This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit: https://www.medscape.com/author/bob-harrington

Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine. https://www.jagsinghmd.com/book

COVID-19 Hits Physician Couple: Dramatically Different Responses

https://www.medscape.com/viewarticle/928530

Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study

https://doi.org/10.1016/j.ijcard.2021.01.002

The Care of the Patient

https://doi.org/10.1001/jama.1927.02680380001001

Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes

https://doi.org/10.1097/mop.0000000000001140

Social determinants of telemedicine utilization in ambulatory cardiovascular patients during the COVID-19 pandemic

https://doi.org/10.1093/ehjdh/ztab039

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback, please contact: [email protected]

Robert Harrington, MD and Jenine John, a cardiologist and machine learning research fellow discuss what you need to know about AI and ML in healthcare and where to find some helpful resources.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit: https://www.medscape.com/author/bob-harrington

'One Brave Idea' Recipient on Predicting Who Will Develop CAD

https://www.medscape.com/viewarticle/874536

Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection

https://doi.org/10.1161/circulationaha.121.058696

Application of Artificial Intelligence to the Electrocardiogram

https://doi.org/10.1093/eurheartj/ehab649

Using Machine Learning to Detect Problems in ECG Data Collection

https://www.cinc.org/archives/2011/pdf/0437.pdf

Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs

https://doi.org/10.1161/CIRCEP.119.007284

External Validation of a Widely Implemented Proprietary Sepsis Prediction Model in Hospitalized Patients

http://jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2021.2626

Sepsis Predictor Tool Falls Short in

Emergency Setting

https://www.medscape.com/viewarticle/982534

Dissecting Racial Bias in an Algorithm Used to Manage the Health of Populations

https://doi.org/10.1126/science.aax2342

Geographic Distribution of US Cohorts Used to Train Deep Learning Algorithms https://jamanetwork.com/journals/jama/fullarticle/2770833

Can Medical Algorithms Be Fair? Three Ethical Quandaries and One Dilemma

https://doi.org/10.1136/bmjhci-2021-100445

Healthcare Machine Learning: Getting Started

https://medium.com/@jeninej/healthcare-machine-learning-getting-started-761a7dbb63a2

What Clinicians Should Know About Healthcare AI, Part 1: Why Care About AI?

https://medium.com/@jeninej/what-clinicians-should-know-about-healthcare-ai-part-1-why-care-about-ai-aba6a06f696d

AI in Healthcare Specialization

https://www.coursera.org/specializations/ai-healthcare

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine: https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's, summary and perspective on the top cardiology news each week, on This Week in Cardiology: https://www.medscape.com/twic

Questions or feedback, please contact: [email protected]

Bob Harrington talks to two former colleagues who made a mid- and senior-career switch to pharma and digital tech, respectively. How did they make this decision and what advice do they have for others?

This podcast is intended for healthcare professionals only.

To read a transcript or to comment

https://www.medscape.com/author/bob-harrington

Jeff Bezos - Regret Minimization https://www.youtube.com/watch?v=-qPii5ACVYw

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback, please contact

[email protected]

Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit

https://www.medscape.com/author/bob-harrington

Lipid Lowering

Safety, Tolerability and Efficacy of Up-Titration of Guideline-Directed Medical Therapies for Acute Heart Failure (STRONG-HF): A Multinational, Open-Label, Randomised, Trial

https://doi.org/10.1016/S0140-6736(22)02076-1

Why Combination Lipid-Lowering Therapy Should Be Considered Early in the Treatment of Elevated LDL-C for CV Risk Reduction

https://www.acc.org/latest-in-cardiology/articles/2022/06/01/12/11/why-combination-lipid-lowering-therapy-should-be-considered

Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project)

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.062746

Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease

https://doi.org/10.1016/j.jacc.2022.09.021

Comparative Effects of Low-Dose Rosuvastatin, Placebo and Dietary Supplements on Lipids and Inflammatory Biomarkers

https://doi.org/10.1016/j.jacc.2022.10.013

Antihypertensive Drugs

No Survival Advantage for Either Torsemide or Furosemide in HF: TRANSFORM-HF

https://www.medscape.com/viewarticle/983611

Chlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events

www.nejm.org/doi/full/10.1056/NEJMoa2212270

Antiplatelets

Duration of Antiplatelet Therapy After Complex Percutaneous Coronary Intervention in Patients at High Bleeding Risk: A MASTER DAPT Trial Sub-analysis

https://doi.org/10.1093/eurheartj/ehac284

PANTHER: Should Clopidogrel Become the 'New Aspirin' in CAD?

https://www.medscape.com/viewarticle/980117

P2Y12 Inhibitor Versus Aspirin Monotherapy for Secondary Prevention of Cardiovascular Events: Meta-analysis of Randomized Trials

https://doi.org/10.1093/ehjopen/oeac019

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes

https://doi.org/10.1056/nejmoa0904327

TCT-320 Pharmacokinetic and Pharmacodynamic Profile of PL-ASA, a Novel Phospholipid-Aspirin Complex Liquid Formulation, Compared to Enteric-Coated Aspirin at an 81-mg Dose – Results From a Prospective, Randomized, Crossover Study

https://www.jacc.org/doi/10.1016/j.jacc.2021.09.1173

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

https://europepmc.org/article/pmc/pmc8773391

Antithrombins/Factor XI

Rivaroxaban in Patients With a Recent Acute Coronary Syndrome

https://www.nejm.org/doi/full/10.1056/nejmoa1112277

Genetically Determined FXI (Factor XI) Levels and Risk of Stroke

https://doi.org/10.1161/strokeaha.118.022792

Factor XIa Inhibition With Asundexian After Acute Non-cardioembolic Ischaemic Stroke (PACIFIC-Stroke): an International, Randomised, Double-Blind, Placebo-Controlled, Phase 2b Trial

https://doi.org/10.1016/s0140-6736(22)01588-4

Safety of the Oral Factor Xia Inhibitor Asundexian Compared With Apixaban in Patients With Atrial Fibrillation (PACIFIC-AF): a Multicentre, Randomised, Double-Blind, Double-Dummy, Dose-Finding Phase 2 Study

https://doi.org/10.1016/S0140-6736(22)00456-1

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

https://doi.org/10.1161/circulationaha.122.061612

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback? Please contact

[email protected]

In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.

This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit

https://www.medscape.com/author/bob-harrington

COVID Therapies

Therapeutic Anticoagulation With Heparin in Noncritically Ill Patients With Covid-19

https://www.nejm.org/doi/full/10.1056/NEJMoa2105911

Effect of Intermediate/High Versus Low Dose Heparin on the Thromboembolic and Hemorrhagic Risk of Unvaccinated COVID-19 Patients in the Emergency Department

https://doi.org/10.1186/s12873-022-00668-8

Two Old Meds and a DOAC a Bust Across Range of COVID Severity: The ACT Trials

https://www.medscape.com/viewarticle/980049

Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial

http://jamanetwork.com/article.aspx?doi=10.1001/jama.2022.18590

FDA Halts Use of Some COVID Monoclonal Antibodies Due to Omicron

https://www.medscape.com/viewarticle/967210

CT Surgeons Rise to Challenge, Lead Way in COVID Clinical Trials

https://www.sts.org/publications/sts-news/ct-surgeons-rise-challenge-lead-way-covid-clinical-trials

What Do We Know About Long COVID: A Cardiovascular Focus

https://www.medscape.com/viewarticle/981435

COVID-19 and the Heart: Is Cardiology Ready?

https://www.medscape.com/viewarticle/969206

The Stanford RECOVER Trial

https://recovercovid.org/

The Heroes Study

https://heroesresearch.org/

Artificial Intelligence

Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs

https://doi.org/10.1161/CIRCEP.119.007284

The Heartline Study

https://www.heartline.com/about

Evolution of Single-Lead ECG for STEMI Detection Using a Deep Learning Approach

https://doi.org/10.1016/j.ijcard.2021.11.039

Recognizing a Ruler Instead of a Cancer

https://menloml.com/2020/01/11/recognizing-a-ruler-instead-of-a-cancer/

Machine Learning Did Not Beat Logistic Regression in Time Series Prediction for Severe Asthma Exacerbations

https://doi.org/10.1038/s41598-022-24909-9

A Systematic Review Shows No Performance Benefit of Machine Learning Over Logistic Regression for Clinical Prediction Models

https://doi.org/10.1016/j.jclinepi.2019.02.004.

Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection

https://doi.org/10.1161/circulationaha.121.058696

Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram

https://doi.org/10.1016/j.jacc.2019.12.030

Here's Why We're Not Prepared for the Next Wave of Biotech Innovation (by Matthew Herper)

https://www.statnews.com/2022/11/03/why-were-not-prepared-for-next-wave-of-biotech-innovation/

RCTs from China

Bivalirudin Plus a High-Dose Infusion Versus Heparin Monotherapy in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Randomised Trial

https://doi.org/10.1016/S0140-6736(22)01999-7

Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI

https://www.medscape.com/viewarticle/983619

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

Hear John Mandrola, MD's summary and perspective on the top cardiology news each week on This Week in Cardiology

https://www.medscape.com/twic

Questions or feedback? Please contact

[email protected]

Drs Bob Harrington and Betty Raman discuss the cardiovascular impact and long-term sequelae of COVID-19, the potential biology behind multisystem effects, and ongoing research.

This podcast is intended for healthcare professionals only.

To read a transcript or to comment, visit

https://www.medscape.com/author/bob-harrington

Medium-term Effects of SARS-CoV-2 Infection on Multiple Vital Organs, Exercise Capacity, Cognition, Quality of Life and Mental Health, Post-Hospital Discharge

https://doi.org/10.1016/j.eclinm.2020.100683

Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection

https://doi.org/10.1016%2Fj.jacc.2020.06.007

Outcomes Among Confirmed Cases and a Matched Comparison Group in the Long-COVID in Scotland Study https://doi.org/10.1038/s41467-022-33415-5

Long COVID: Post-Acute Sequelae of COVID-19 With a Cardiovascular Focus

https://doi.org/10.1093/eurheartj/ehac031

Cardiovascular Disease and COVID-19: A Consensus Paper From the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in Collaboration With the European Heart Rhythm Association (EHRA)

https://doi.org/10.1093/cvr/cvab298

Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients

https://doi.org/10.3390/ijms222111622

COVID-19 and Fat Embolism: A Hypothesis to Explain the Severe Clinical Outcome in people With Obesity

https://pubmed.ncbi.nlm.nih.gov/32514077

Association Between Epstein-Barr-Virus Reactivation and Development of Long-COVID Fatigue

https://doi.org/10.1111/all.15471

Activation or Exhaustion of CD8+ T Cells in Patients With COVID-19

https://doi.org/10.1038/s41423-021-00750-4

Skeletal Muscle Alterations in Patients With Acute COVID-19 and Post-Acute Sequelae of COVID-19

https://doi.org/10.1002/jcsm.12896

Gut Microbiota Dynamics in a Prospective Cohort of Patients With Post-Acute COVID-19 Syndrome

http://dx.doi.org/10.1136/gutjnl-2021-325989

COVID-Vaccine Myocarditis: Rare, Mild, and Usually a Guy Thing

https://www.medscape.com/viewarticle/966244

Myocardial Injury Pattern at MRI in COVID-19 Vaccine–Associated Myocarditis

https://doi.org/10.1148/radiol.212559

Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19 via Cytokine Storm?

https://doi.org/10.3389/fimmu.2020.607734

Myocarditis Associated With COVID-19 Vaccination

https://doi.org/10.1161/CIRCIMAGING.121.013236

COVID and the Athlete's Heart

https://www.medscape.com/viewarticle/945282

COVID-19 and the Heart: Is Cardiology Ready?

https://www.medscape.com/viewarticle/969206

Lung Abnormalities Depicted With Hyperpolarized Xenon MRI in Patients With Long COVID

https://doi.org/10.1148/radiol.220069

Long COVID Resource Center

https://www.medscape.com/resource/long-covid

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine.

Hear John Mandrola, MD's, summary and perspective on the top cardiology news each week on This Week in Cardiology.

Questions or feedback, please contact [email protected]